Insider · CIK 0001467361
Uri Geiger
Files at NPCE (NeuroPace Inc). First filing -, latest -.
In brief
Uri Geiger files SEC Form 4 as director at NPCE (NeuroPace Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Uri Geiger has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 19, 2026 | NPCE NeuroPace Inc | AGrant or award Common Stock | +789 | $15.63 | $12k | 18,537 | Jun 22, 2026 |
| Jun 5, 2026 | NPCE NeuroPace Inc | AGrant or award Common Stock | +2,890 | $0.00 | $0 | 17,748 | Jun 5, 2026 |
| Jun 5, 2026 | NPCE NeuroPace Inc | AGrant or award Stock Option (Right to Buy)derivative | +5,368 | $0.00 | $0 | 5,368 | Jun 5, 2026 |
| Mar 20, 2026 | NPCE NeuroPace Inc | AGrant or award Common Stock | +913 | $13.00 | $12k | 14,858 | Mar 24, 2026 |
| Dec 19, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +715 | $16.59 | $12k | 13,945 | Dec 23, 2025 |
| Sep 19, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,194 | $9.94 | $12k | 13,230 | Sep 22, 2025 |
| Jun 30, 2023 | NPCE NeuroPace Inc | AGrant or award Common Stock | +2,337 | $4.49 | $10k | 2,337 | Jun 24, 2025 |
| Sep 29, 2023 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,220 | $9.73 | $12k | 3,557 | Jun 24, 2025 |
| Dec 29, 2023 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,151 | $10.31 | $12k | 4,708 | Jun 24, 2025 |
| Mar 29, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +899 | $13.20 | $12k | 5,607 | Jun 24, 2025 |
| Jun 28, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,570 | $7.56 | $12k | 7,177 | Jun 24, 2025 |
| Sep 30, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,703 | $6.97 | $12k | 8,880 | Jun 24, 2025 |
| Dec 21, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,029 | $11.53 | $12k | 9,909 | Jun 24, 2025 |
| Mar 21, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +987 | $12.02 | $12k | 10,896 | Jun 24, 2025 |
| Jun 21, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +1,140 | $10.41 | $12k | 12,036 | Jun 24, 2025 |
| Jun 6, 2025 | NPCE NeuroPace Inc | AGrant or award Stock Option (right to buy)derivative | +8,745 | $0.00 | $0 | 8,745 | Jun 9, 2025 |
Questions about Uri Geiger
Answered from the filings on this page, as of the latest one.
Is Uri Geiger buying or selling?
Uri Geiger has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Uri Geiger's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Uri Geiger has 0.
Where does Uri Geiger file Form 4?
Uri Geiger has filed Form 4 at NPCE (NeuroPace Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.